EVO Stock Summary and Trading Ideas (Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share | NASDAQ:EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share trades on the NASDAQ stock market under the symbol EVO.

As of January 30, 2026, EVO stock price declined to $3.65 with 48,107 million shares trading.

EVO has a beta of 1.23, meaning it tends to be more sensitive to market movements. EVO has a correlation of 0.13 to the broad based SPY ETF.

EVO has a market cap of $1.30 billion. This is considered a Small Cap stock.

Last quarter Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share reported $192 million in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-46 million and met earnings estimates .

In the last 3 years, EVO traded as high as $13.49 and as low as $2.84.

EVO has underperformed the market in the last year with a return of -18.7%, while the SPY ETF gained +15.6%. In the last 3 month period, EVO fell short of the market, returning -10.1%, while SPY returned +2.1%. However, in the most recent 2 weeks EVO has outperformed the stock market by returning +1.1%, while SPY returned 0.0%.

EVO support price is $3.66 and resistance is $3.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVO shares will trade within this expected range on the day.